Rosamox
Asia Pacific Rosamox Efficacy Tests
In Vitro Studies
- Antioxidant activity: Inhibition of reactive oxygen species (ROS) following UVB irradiation exposure
- Soothing effect: Reduction of IL-6 and IL-8 pro-inflammatory cytokine release
- Protection of collagen and elastin fibers: Reduction of MMP-1 and MMP-3 production
- Youthful skin: Enhancement of elastin and hyaluronic acid synthesis
- Anti-glycation property: Inhibition of Advanced Glycation End products (AGE’s)
Clinical Study
Skin conditioning effect: D-squame® test
D-Squame® is a registered trademark of CuDerm Corporation